Skip to main content

Reactions Weekly

Ausgabe 1/2020 May 2, 2020

Inhalt (276 Artikel)

Alcohol

  • Case report

Alemtuzumab

  • Case report

Alemtuzumab

  • Case report

Alemtuzumab

  • Case report

Alemtuzumab

  • Case report

Alemtuzumab

  • Case report

Alemtuzumab

  • Case report

Alemtuzumab

  • Case report

Amiodarone

  • Case report

Amiodarone/dobutamine

  • Case report

Antibacterials

  • Case report

Antibacterials

  • Case report

Antineoplastics

  • Case report

Antineoplastics

  • Case report

Antineoplastics

  • Case report

Antineoplastics

  • Case report

Antineoplastics

  • Case report

Antineoplastics

  • Case report

Antineoplastics

  • Case report

Antineoplastics

  • Case report

Antiretrovirals

  • Case report

Antituberculars

  • Case report

Apixaban

  • Case report

Argatroban

  • Case report

Ascorbic acid

  • Case report

Aspirin

  • Case report

Atezolizumab

  • Case report

Atorvastatin

  • Case report

Atorvastatin

  • Case report

Azathioprine

  • Case report

Azathioprine

  • Case report

Baclofen

  • Case report

Bevacizumab

  • Case report

Biapenem/vancomycin

  • Case report

Botulinum toxin-A

  • Case report

Botulinum toxin-A

  • Case report

Cabazitaxel

  • Case report

Calcium-gluconate

  • Case report

Camrelizumab

  • Case report

Carfilzomib

  • Case report

Ciclosporin

  • Case report

Ciclosporin

  • Case report

Cisplatin/gemcitabine

  • Case report

Clopidogrel

  • Case report

Colchicine overdose

  • Case report

Colecalciferol

  • Case report

Cotrimoxazole

  • Case report

Cotrimoxazole/dapsone

  • Case report

Crizotinib

  • Case report

Cyclophosphamide

  • Case report

Cyclophosphamide

  • Case report

Daclatasvir

  • Case report

Daratumumab

  • Case report

Dexamethasone

  • Case report

Dexamethasone

  • Case report

Digoxin

  • Case report

Dimethyl-fumarate

  • Case report

Dimeticone

  • Case report

Docetaxel

  • Case report

Docetaxel

  • Case report

Doxorubicin-liposomal

  • Case report

Duloxetine

  • Case report

Durvalumab

  • Case report

Eculizumab

  • Case report

Elbasvir/grazoprevir

  • Case report

Eltrombopag

  • Case report

Eltrombopag

  • Case report

Enzalutamide

  • Case report

Eribulin

  • Case report

Ezetimibe

  • Case report

Factor-VIII/sirolimus

  • Case report

Fingolimod

  • Case report

Fingolimod

  • Case report

Fingolimod

  • Case report

Fingolimod withdrawal

  • Case report

Flecainide

  • Case report

Fluconazole

  • Case report

Fludarabine/melphalan

  • Case report

Fluorouracil

  • Case report

Gemcitabine

  • Case report

Immunosuppressants

  • Case report

Immunosuppressants

  • Case report

Immunosuppressants

  • Case report

Immunosuppressants

  • Case report

Immunosuppressants

  • Case report

Immunosuppressants

  • Case report

Immunosuppressants

  • Case report

Infliximab

  • Case report

Infliximab

  • Case report

Insulin abuse

  • Case report

Interferon-alpha-2a

  • Case report

Iohexol

  • Case report

Ipilimumab

  • Case report

Ipilimumab/nivolumab

  • Case report

Ipilimumab/nivolumab

  • Case report

Ipilimumab/nivolumab

  • Case report

Isoprenaline

  • Case report

Isotretinoin

  • Case report

Isotretinoin

  • Case report

Ketamine

  • Case report

Lamotrigine

  • Case report

Levodopa/benserazide

  • Case report

Lithium

  • Case report

Maltose

  • Case report

Medi-3250

  • Case report

Metformin

  • Case report

Methotrexate

  • Case report

Methotrexate

  • Case report

Methylprednisolone

  • Case report

Methylprednisolone

  • Case report

Methylprednisolone

  • Case report

Midazolam/morphine

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Multiple drugs

  • Case report

Mycophenolate-mofetil

  • Case report

Nadolol

  • Case report

Natalizumab

  • Case report

Natalizumab

  • Case report

Nitroglycerin

  • Case report

Nivolumab

  • Case report

Nivolumab

  • Case report

Nivolumab

  • Case report

Nivolumab

  • Case report

Nivolumab

  • Case report

Nivolumab/prednisone

  • Case report

Nusinersen

  • Case report

Ocrelizumab

  • Case report

Ocrelizumab

  • Case report

Opioid-analgesics

  • Case report

Osimertinib

  • Case report

Osimertinib

  • Case report

Oxycodone

  • Case report

Paclitaxel

  • Case report

Paracetamol

  • Case report

Pazopanib

  • Case report

Pembrolizumab

  • Case report

Pembrolizumab

  • Case report

Pembrolizumab

  • Case report

Pembrolizumab

  • Case report

Pentostatin

  • Case report

Permethrin

  • Case report

Phenytoin overdose

  • Case report

Plasma

  • Case report

Pneumococcal-vaccine

  • Case report

Prednisolone acetate

  • Case report

Prednisone

  • Case report

Prednisone/tacrolimus

  • Case report

Riluzole

  • Case report

Risperidone/trazodone

  • Case report

Rituximab

  • Case report

Rituximab

  • Case report

Rituximab

  • Case report

Rivaroxaban

  • Case report

Ruxolitinib

  • Case report

Ruxolitinib

  • Case report

Secukinumab

  • Case report

Shishihakuhito

  • Case report

Sildenafil overdose

  • Case report

Simeprevir/sofosbuvir

  • Case report

Tacrolimus

  • Case report

Tacrolimus

  • Case report

Tacrolimus

  • Case report

Tacrolimus

  • Case report

Tamoxifen

  • Case report

Ticagrelor

  • Case report

Voriconazole

  • Case report

Voriconazole

  • Case report

Warfarin

  • Case report